Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RUNX1 antisense RNA 2 (RUNX1-AS2) is a human long non-coding RNA transcribed in the antisense orientation at the RUNX1 locus. It does not encode a protein. There is little direct experimental characterization of its function in the literature. Unlike coding genes (such as RUNX1), RUNX1-AS2 is not currently recognized as a therapeutic target, biomarker, or direct modulator of disease processes. It should not be confused with other non-coding RNAs at the same locus (such as "RUNXOR" or "RUNX1 overlapping RNA"), which have some published functions in leukemia[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RUNX1 antisense RNA 2 (RUNX1-AS2).